Brachytherapy Afterloader System from Canada
High-dose rate brachytherapy device delivering Iridium-192 sources directly into tumors for precise radiation therapy. Used in nonprofit cancer centers for prostate and gynecological treatments. Qualifies under HTS 9810.00.80.00 as integral radioactive therapeutic apparatus.
Duty Rate — Canada → United States
10%
Rate breakdown
9903.05.2910%Except for products described in headings 9903.05.85–9903.05.93, articles the product of Canada, as provided for in U.S. note 52 to this subchapter
Import Tips
• Include NRC/AEC source material license and institutional radiation safety plan
• Document apparatus design confirming integral radioactive source delivery mechanism
• Maintain records proving exclusive therapeutic use in nonprofit institutions